4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0000950170-25-110774
Chief Legal Officer sold 676 shares at $26.59 ($17,975)
From the SEC's structured data for this filing
Trades in this filing
Wilson Mark Andrew · Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-19 | Sale : show line 1 in the form | −676 | $26.59 | $17,975 | 20,312 | D |
| Open-market sales · 676 sh · avg $26.59 · $17,975 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-19 | Grant or award : show line 2 in the form Stock Option | +21,666 | 21,666 | D |
Loading xslF345X05/ownership.xml…